253 related articles for article (PubMed ID: 25748296)
1. The metabolic syndrome in a memory clinic population: relation with clinical profile and prognosis.
Exalto LG; van der Flier WM; van Boheemen CJM; Kappelle LJ; Vrenken H; Teunissen C; Koene T; Scheltens P; Biessels GJ
J Neurol Sci; 2015 Apr; 351(1-2):18-23. PubMed ID: 25748296
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Syndrome and cognitive decline in the elderly: A systematic review.
Assuncao N; Sudo FK; Drummond C; de Felice FG; Mattos P
PLoS One; 2018; 13(3):e0194990. PubMed ID: 29579115
[TBL] [Abstract][Full Text] [Related]
3. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
[TBL] [Abstract][Full Text] [Related]
4. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort.
Ng TP; Feng L; Nyunt MS; Feng L; Gao Q; Lim ML; Collinson SL; Chong MS; Lim WS; Lee TS; Yap P; Yap KB
JAMA Neurol; 2016 Apr; 73(4):456-63. PubMed ID: 26926205
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
Pedersen KF; Larsen JP; Tysnes OB; Alves G
JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
[TBL] [Abstract][Full Text] [Related]
7. Association between depressive symptoms and cognitive impairment in patients with metabolic syndrome.
Kopchak O; Pulyk O
Wiad Lek; 2017; 70(4):737-741. PubMed ID: 29064796
[TBL] [Abstract][Full Text] [Related]
8. Significance of subjective memory complaints in the clinical setting.
Silva D; Guerreiro M; Faria C; Maroco J; Schmand BA; Mendonça Ad
J Geriatr Psychiatry Neurol; 2014 Dec; 27(4):259-65. PubMed ID: 24763068
[TBL] [Abstract][Full Text] [Related]
9. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
Galtier I; Nieto A; Lorenzo JN; Barroso J
J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
[TBL] [Abstract][Full Text] [Related]
10. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study.
Tondelli M; Bedin R; Chiari A; Molinari MA; Bonifacio G; Lelli N; Trenti T; Nichelli P
Clin Chem Lab Med; 2015 Feb; 53(3):453-60. PubMed ID: 25274948
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Syndrome, Mild Cognitive Impairment, and Dementia: A Meta-Analysis of Longitudinal Studies.
Atti AR; Valente S; Iodice A; Caramella I; Ferrari B; Albert U; Mandelli L; De Ronchi D
Am J Geriatr Psychiatry; 2019 Jun; 27(6):625-637. PubMed ID: 30917904
[TBL] [Abstract][Full Text] [Related]
12. Age related characteristics of cognitive changes in patients with metabolic syndrome.
Bezrukov VV; Bachinskaya NY; Kopchak OO; Kholin VO; Pulyk OR
Wiad Lek; 2018; 71(8):1515-1523. PubMed ID: 30684334
[TBL] [Abstract][Full Text] [Related]
13. The Cognitive Assessment Battery (CAB): a rapid test of cognitive domains.
Nordlund A; Påhlsson L; Holmberg C; Lind K; Wallin A
Int Psychogeriatr; 2011 Sep; 23(7):1144-51. PubMed ID: 21251350
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging.
Solfrizzi V; Scafato E; Capurso C; D'Introno A; Colacicco AM; Frisardi V; Vendemiale G; Baldereschi M; Crepaldi G; Di Carlo A; Galluzzo L; Gandin C; Inzitari D; Maggi S; Capurso A; Panza F;
Neurobiol Aging; 2011 Nov; 32(11):1932-41. PubMed ID: 20045217
[TBL] [Abstract][Full Text] [Related]
16. Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.
Mazzeo S; Santangelo R; Bernasconi MP; Cecchetti G; Fiorino A; Pinto P; Passerini G; Falautano M; Comi G; Magnani G
J Alzheimers Dis; 2016 Oct; 54(4):1495-1508. PubMed ID: 27589522
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological characteristics of mild vascular cognitive impairment and dementia after stroke.
Stephens S; Kenny RA; Rowan E; Allan L; Kalaria RN; Bradbury M; Ballard CG
Int J Geriatr Psychiatry; 2004 Nov; 19(11):1053-7. PubMed ID: 15481073
[TBL] [Abstract][Full Text] [Related]
18. The metabolic syndrome, atherosclerosis and cognitive functioning in a non-demented population: the Hoorn Study.
Reijmer YD; van den Berg E; Dekker JM; Nijpels G; Stehouwer CD; Kappelle LJ; Biessels GJ
Atherosclerosis; 2011 Dec; 219(2):839-45. PubMed ID: 21959256
[TBL] [Abstract][Full Text] [Related]
19. Alabama Brief Cognitive Screener: Utility of a New Cognitive Screening Instrument in a Memory Disorders Clinic.
Love MCN; Pilonieta G; Geldmacher DS
Prim Care Companion CNS Disord; 2019 Mar; 21(2):. PubMed ID: 30896091
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Syndrome and Cognitive Impairment among High Socioeconomic, Nondemented Older US Adults.
Martinez-Miller EE; Kohl HW; Barlow CE; Willis BL; DeFina LF
J Am Geriatr Soc; 2019 Jul; 67(7):1437-1443. PubMed ID: 30854644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
